Peter Lee
22Patents
4h-index
14Co-inventors
60Inventor score
Filing activity: Apr 22, 1985 → Oct 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5733540A | Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria | Chemistry; Metallurgy | 58 | Expired |
| USD290777S | Polish applicator mitt | General | 16 | Expired |
| US8435762B2 | Chimeric ligand-gated ion channels and methods of use thereof | Human Necessities | 13 | Active |
| US6365156B1 | Method for improving the half-life of soluble viral-specific ligands on mucosal membranes | Emerging Cross-Sectional Technologies | 12 | Expired |
| US4804413A | Shoe polish composition | Chemistry; Metallurgy | 4 | Expired |
| US10481159B2 | IL-6 signaling and breast cancer | Physics | 2 | Active |
| US10961296B2 | Modified ligand-gated ion channels and methods of use | Chemistry; Metallurgy | 1 | Active |
| US11124554B2 | Modified ligand-gated ion channels and methods of use | Chemistry; Metallurgy | 1 | Active |
| US10981962B2 | Modified ligand-gated ion channels and methods of use | Chemistry; Metallurgy | 1 | Active |
| US11084853B2 | Modified ligand-gated ion channels and methods of use | Chemistry; Metallurgy | 1 | Active |
| US9488644B2 | Assays for determining the effect of an immune cell on a cell from an infectious or neoplastic disease | Chemistry; Metallurgy | 1 | Active |
| US11187704B2 | IL-6 signaling and breast cancer | Physics | 1 | Active |
| US10072308B2 | Molecular detection of enterovirus and parechovirus | Emerging Cross-Sectional Technologies | 1 | Active |
| US10137153B2 | Methods for treating an infectious or neoplastic disease | Chemistry; Metallurgy | 1 | Active |
| US12385920B2 | IL-6 signaling and breast cancer | Physics | 0 | Active |
| US10724111B2 | Molecular detection of enterovirus and parechovirus | Emerging Cross-Sectional Technologies | 0 | Active |
| US10697002B2 | Amplification and detection of nucleic acids in a biological sample | Emerging Cross-Sectional Technologies | 0 | Active |
| US11058700B2 | Macrocyclic lactones and uses thereof as modulators of purinergic receptors | Human Necessities | 0 | Active |
| US10316372B2 | Molecular detection of enterovirus and parechovirus | Emerging Cross-Sectional Technologies | 0 | Active |
| US10912798B2 | Methods for treating an infectious or neoplastic disease | Chemistry; Metallurgy | 0 | Active |
| US12247064B2 | Modified ligand-gated ion channels and methods of use | Chemistry; Metallurgy | 0 | Active |
| US7598223B2 | Methods for producing target cell reactive lymphocytes | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.